Normobaric hyperoxia in wartime pediatric trauma casualties

Jason F Naylor1, Matthew A Borgman2, Michael D April2

  • 1Madigan Army Medical Center, Joint Base Lewis-McChord, Washington 98431, United States of America.

Insights

Hyperoxia therapy, or high oxygen levels, was common in pediatric trauma patients but did not impact survival outcomes. This study found no significant difference in survival rates for children with hyperoxemia versus those without.

Area of Science:

  • Pediatric critical care medicine
  • Trauma surgery
  • Emergency medicine

Background:

  • Hyperoxia therapy is increasingly recognized for potential harm in critically ill patients.
  • Pediatric trauma casualties in wartime settings present unique challenges for oxygen management.
  • Understanding the impact of oxygen levels on survival is crucial for optimizing care.

Purpose of the Study:

  • To investigate the relationship between arterial oxygen levels and survival in pediatric trauma patients.
  • To analyze injury characteristics and outcomes stratified by partial pressure of arterial oxygen (PaO2).
  • To conduct subgroup analyses for severe traumatic brain injury (TBI) and massive transfusion (MT).

Main Methods:

  • Utilized Department of Defense Trauma Registry data from January 2007 to January 2016.
  • Included pediatric (<18 years) trauma casualties with available arterial blood gas (ABG) data.
  • Stratified patients into normoxemia, hyperoxemia (PaO2 100-300 mmHg), and extreme hyperoxemia (PaO2 >300 mmHg) groups.

Main Results:

  • Out of 1323 pediatric trauma patients with ABG, 22% had hyperoxemia and 3.3% had extreme hyperoxemia.
  • No significant differences in survival rates were observed between normoxemia, hyperoxemia, and extreme hyperoxemia groups (92% vs. 87% vs. 86%, p=0.078).
  • Subgroup analyses for TBI and MT also showed no significant survival differences, and multivariable analyses did not indicate increased odds of survival with higher oxygen levels.

Conclusions:

  • Hyperoxemia is a frequent finding in hospitalized pediatric wartime trauma casualties.
  • Survival to hospital discharge was not significantly different between pediatric trauma patients with or without hyperoxemia.
  • Current findings do not support a detrimental effect of hyperoxemia on survival in this specific cohort.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260